Physician profile
Julian E Bailes
NPI 1225138001
$666,306.70
in general payments reported to CMS, 2019-2025
12 companies · $10K in 2025
The $10K reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149K · 2020: $125K · 2021: $116K · 2022: $71K · 2023: $71K · 2024: $125K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $180K · Royalty Or License: $25K · Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $179,800.00 |
| Royalty Or License | $24,697.59 |
| Food and Beverage | $1,360.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jan Medical INC. | $540,000.00 | 2019-2025 | |
| Mizuho America, INC. | $49,642.34 | 2019-2024 | |
| Stryker Corporation | $32,003.56 | 2021-2024 | Mild Device Kit |
| Eagle Pharmaceuticals, INC. | $22,289.36 | 2019 | |
| Nico Corporation | $21,613.33 | 2020-2024 | |
| Kuros Biosciences USA, INC | $211.98 | 2024 | Magnetos |
| Providence Medical Technology, INC. | $208.56 | 2024 | |
| Carl Zeiss Meditec, INC. | $94.67 | 2019 | |
| Medtronic USA, INC. | $70.74 | 2019-2020 | |
| Medtronic, INC. | $68.22 | 2021-2024 | Stealth Autoguide System |
| Turing Medical Technologies | $52.34 | 2023 | |
| Gt Medical Technologies, INC | $51.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julian Bailes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.